Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.
作者信息
Yoshida Soichiro, Fujii Yasuhisa
机构信息
Department of Urology Tokyo Medical and Dental University Tokyo Japan.
出版信息
IJU Case Rep. 2020 Dec 15;4(2):73-74. doi: 10.1002/iju5.12248. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.关于全身扩散加权磁共振成像在治疗相关神经内分泌前列腺癌管理中的效用的社论评论
IJU Case Rep. 2020 Dec 15;4(2):73-74. doi: 10.1002/iju5.12248. eCollection 2021 Mar.
2
Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.全身弥散加权磁共振成像在治疗相关神经内分泌前列腺癌管理中的应用价值
IJU Case Rep. 2020 Nov 29;4(2):69-73. doi: 10.1002/iju5.12242. eCollection 2021 Mar.
3
Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond.全身扩散加权磁共振成像：前列腺癌及其他疾病的诊断与随访
Int J Urol. 2021 May;28(5):502-513. doi: 10.1111/iju.14497. Epub 2021 Mar 6.
4
Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors.全身磁共振成像联合弥散加权成像与传统成像用于神经内分泌肿瘤随访的前瞻性比较
Endocrine. 2020 Jan;67(1):243-251. doi: 10.1007/s12020-019-02095-5. Epub 2019 Sep 28.
5
Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy.扩展前列腺活检中单侧前列腺癌患者的弥散加权磁共振成像：侧别预测准确性及其对半根治性治疗的影响。
J Urol. 2010 Nov;184(5):1963-9. doi: 10.1016/j.juro.2010.06.136. Epub 2010 Sep 18.
6
Diffusion-weighted magnetic resonance imaging detects significant prostate cancer with high probability.弥散加权磁共振成像能以高概率检测出显著的前列腺癌。
J Urol. 2014 Sep;192(3):737-42. doi: 10.1016/j.juro.2014.03.039. Epub 2014 Mar 15.
7
Editorial comment on: A study of diffusion-weighted magnetic resonance imaging in men with untreated localized prostate cancer on active surveillance.
Eur Urol. 2009 Dec;56(6):987-8. doi: 10.1016/j.eururo.2008.11.052. Epub 2008 Dec 6.
8
Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.弥散加权磁共振成像上的肿瘤病变直径有助于预测有资格接受主动监测的患者中无意义的前列腺癌：初步分析。
J Urol. 2013 Oct;190(4):1213-7. doi: 10.1016/j.juro.2013.03.127. Epub 2013 May 28.
9
A Multicompartmental Diffusion Model for Improved Assessment of Whole-Body Diffusion-weighted Imaging Data and Evaluation of Prostate Cancer Bone Metastases.一种用于改善全身扩散加权成像数据评估和前列腺癌骨转移评估的多室扩散模型。
Radiol Imaging Cancer. 2023 Jan;5(1):e210115. doi: 10.1148/rycan.210115.
10
Detecting prostate cancer and prostatic calcifications using advanced magnetic resonance imaging.使用先进的磁共振成像检测前列腺癌和前列腺钙化。
Asian J Androl. 2017 Jul-Aug;19(4):439-443. doi: 10.4103/1008-682X.177840.
本文引用的文献
1
Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.全身弥散加权磁共振成像在治疗相关神经内分泌前列腺癌管理中的应用价值
IJU Case Rep. 2020 Nov 29;4(2):69-73. doi: 10.1002/iju5.12242. eCollection 2021 Mar.
2
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.晚期前列腺癌患者的管理：2019年晚期前列腺癌共识会议报告
Eur Urol. 2020 Apr;77(4):508-547. doi: 10.1016/j.eururo.2020.01.012. Epub 2020 Jan 27.
3
Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL.转移性去势抵抗性前列腺癌中前列腺特异性抗原（PSA）未升高情况下的影像学进展：PREVAIL研究的事后分析
Prostate Cancer Prostatic Dis. 2017 Jun;20(2):221-227. doi: 10.1038/pcan.2016.71. Epub 2017 Jan 24.
4
Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?全身磁共振弥散加权成像能否替代 Tc 99m 骨扫描和 CT 进行高危前列腺癌患者的一步法转移检测？
Eur Urol. 2012 Jul;62(1):68-75. doi: 10.1016/j.eururo.2012.02.020. Epub 2012 Feb 17.
5
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.磁共振扩散加权成像作为一种癌症生物标志物：共识与建议
Neoplasia. 2009 Feb;11(2):102-25. doi: 10.1593/neo.81328.
Zotero 插件